Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukodystrophy, Metachromatic | 20 | 2022 | 42 | 6.650 |
Why?
|
Lysosomal Storage Diseases | 8 | 2021 | 79 | 3.250 |
Why?
|
Cerebroside-Sulfatase | 9 | 2022 | 14 | 2.440 |
Why?
|
Lentivirus | 16 | 2022 | 498 | 2.290 |
Why?
|
Hematopoietic Stem Cells | 19 | 2023 | 3353 | 2.220 |
Why?
|
Hematopoietic Stem Cell Transplantation | 33 | 2022 | 5215 | 2.160 |
Why?
|
Microglia | 9 | 2019 | 1213 | 1.500 |
Why?
|
Mucopolysaccharidosis I | 5 | 2020 | 51 | 1.400 |
Why?
|
Adrenoleukodystrophy | 5 | 2020 | 115 | 1.400 |
Why?
|
Genetic Vectors | 19 | 2022 | 3447 | 1.360 |
Why?
|
Iduronidase | 4 | 2020 | 31 | 1.230 |
Why?
|
Metallothionein | 2 | 2018 | 64 | 1.130 |
Why?
|
Central Nervous System | 4 | 2023 | 1301 | 1.090 |
Why?
|
Galactosylceramidase | 5 | 2015 | 20 | 1.040 |
Why?
|
Wiskott-Aldrich Syndrome | 3 | 2022 | 136 | 1.020 |
Why?
|
Leukodystrophy, Globoid Cell | 6 | 2019 | 33 | 1.000 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 2 | 2019 | 139 | 0.830 |
Why?
|
beta-Thalassemia | 5 | 2019 | 226 | 0.810 |
Why?
|
Lysosomal Storage Diseases, Nervous System | 2 | 2012 | 9 | 0.810 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2020 | 43 | 0.760 |
Why?
|
Anemia, Sickle Cell | 5 | 2023 | 984 | 0.760 |
Why?
|
Gangliosidoses | 1 | 2019 | 7 | 0.740 |
Why?
|
Mucopolysaccharidoses | 1 | 2019 | 26 | 0.720 |
Why?
|
Homocystinuria | 1 | 2018 | 65 | 0.650 |
Why?
|
Italy | 8 | 2022 | 818 | 0.650 |
Why?
|
Hematology | 2 | 2021 | 212 | 0.640 |
Why?
|
Blood Component Removal | 1 | 2018 | 118 | 0.630 |
Why?
|
Coronavirus | 1 | 2020 | 147 | 0.630 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2018 | 222 | 0.620 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 250 | 0.620 |
Why?
|
Stem Cell Niche | 2 | 2011 | 347 | 0.610 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2023 | 164 | 0.580 |
Why?
|
Transduction, Genetic | 7 | 2019 | 923 | 0.580 |
Why?
|
Hydrolases | 1 | 2017 | 137 | 0.570 |
Why?
|
Brain Damage, Chronic | 1 | 2017 | 266 | 0.570 |
Why?
|
Saposins | 1 | 2015 | 26 | 0.550 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2015 | 24 | 0.540 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2015 | 20 | 0.530 |
Why?
|
Leukemia | 2 | 2022 | 1494 | 0.530 |
Why?
|
Gene Transfer Techniques | 6 | 2019 | 1242 | 0.530 |
Why?
|
Cerebral Ventricles | 1 | 2017 | 539 | 0.530 |
Why?
|
Metabolic Diseases | 2 | 2020 | 654 | 0.500 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 399 | 0.460 |
Why?
|
Polymers | 1 | 2019 | 1627 | 0.410 |
Why?
|
Regenerative Medicine | 1 | 2015 | 303 | 0.410 |
Why?
|
Molecular Dynamics Simulation | 1 | 2014 | 388 | 0.400 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 945 | 0.400 |
Why?
|
Transplantation Conditioning | 3 | 2019 | 1553 | 0.390 |
Why?
|
Nanoparticles | 2 | 2019 | 1901 | 0.380 |
Why?
|
Disease Models, Animal | 12 | 2023 | 18033 | 0.340 |
Why?
|
Animals | 38 | 2023 | 168714 | 0.340 |
Why?
|
Nervous System Diseases | 2 | 2017 | 1620 | 0.340 |
Why?
|
Mice | 29 | 2023 | 80300 | 0.330 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2021 | 176 | 0.320 |
Why?
|
Brain | 11 | 2023 | 25764 | 0.320 |
Why?
|
Bone Marrow | 4 | 2023 | 2908 | 0.320 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 2 | 2022 | 165 | 0.310 |
Why?
|
Isoquinolines | 1 | 2009 | 367 | 0.310 |
Why?
|
MicroRNAs | 5 | 2023 | 3715 | 0.310 |
Why?
|
Transgenes | 3 | 2019 | 1016 | 0.300 |
Why?
|
Humans | 87 | 2023 | 725187 | 0.300 |
Why?
|
Mice, Inbred C57BL | 12 | 2019 | 22134 | 0.300 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1805 | 0.300 |
Why?
|
Immunotherapy, Adoptive | 1 | 2015 | 1105 | 0.290 |
Why?
|
Natural Killer T-Cells | 1 | 2009 | 312 | 0.280 |
Why?
|
Child | 32 | 2023 | 75163 | 0.280 |
Why?
|
Antigens, CD34 | 4 | 2019 | 653 | 0.280 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2099 | 0.280 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2692 | 0.280 |
Why?
|
Mental Health | 1 | 2020 | 2842 | 0.280 |
Why?
|
Regeneration | 1 | 2015 | 1513 | 0.270 |
Why?
|
Flow Cytometry | 5 | 2019 | 5968 | 0.270 |
Why?
|
Mice, Knockout | 13 | 2019 | 14769 | 0.270 |
Why?
|
Anxiety | 1 | 2020 | 4079 | 0.270 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3111 | 0.270 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3221 | 0.270 |
Why?
|
Neuroblastoma | 2 | 2023 | 1180 | 0.260 |
Why?
|
Central Nervous System Diseases | 1 | 2009 | 523 | 0.250 |
Why?
|
Virus Integration | 4 | 2019 | 298 | 0.250 |
Why?
|
Receptors, GABA-A | 1 | 2009 | 629 | 0.250 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1638 | 0.240 |
Why?
|
Pandemics | 2 | 2020 | 7851 | 0.240 |
Why?
|
Communicable Diseases | 2 | 2022 | 828 | 0.240 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2023 | 20 | 0.230 |
Why?
|
gamma-Globins | 2 | 2020 | 94 | 0.230 |
Why?
|
Immunophenotyping | 3 | 2021 | 1866 | 0.220 |
Why?
|
Cell Differentiation | 8 | 2023 | 11507 | 0.220 |
Why?
|
Cyclosporine | 2 | 2019 | 791 | 0.220 |
Why?
|
Interleukin-7 | 1 | 2022 | 140 | 0.210 |
Why?
|
Histiocytosis | 1 | 2021 | 39 | 0.210 |
Why?
|
Paramyxoviridae Infections | 1 | 2021 | 54 | 0.200 |
Why?
|
B-Lymphocyte Subsets | 1 | 2022 | 252 | 0.200 |
Why?
|
Agammaglobulinemia | 1 | 2022 | 178 | 0.200 |
Why?
|
Sulfoglycosphingolipids | 2 | 2013 | 19 | 0.200 |
Why?
|
Adenoviridae Infections | 1 | 2021 | 100 | 0.200 |
Why?
|
Fetal Hemoglobin | 2 | 2020 | 342 | 0.200 |
Why?
|
Familial Mediterranean Fever | 1 | 2021 | 61 | 0.190 |
Why?
|
Histiocytic Sarcoma | 1 | 2021 | 45 | 0.190 |
Why?
|
Macrophage Activation Syndrome | 1 | 2021 | 95 | 0.190 |
Why?
|
Nephrocalcinosis | 1 | 2020 | 50 | 0.190 |
Why?
|
Enzyme Replacement Therapy | 2 | 2019 | 77 | 0.190 |
Why?
|
Stomatitis | 1 | 2023 | 260 | 0.190 |
Why?
|
Green Fluorescent Proteins | 3 | 2017 | 2121 | 0.190 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2020 | 75 | 0.190 |
Why?
|
Depression | 1 | 2020 | 7454 | 0.190 |
Why?
|
In Situ Nick-End Labeling | 2 | 2012 | 646 | 0.190 |
Why?
|
Comparative Genomic Hybridization | 1 | 2021 | 503 | 0.180 |
Why?
|
Reed-Sternberg Cells | 1 | 2020 | 73 | 0.180 |
Why?
|
Mutation | 5 | 2022 | 29672 | 0.180 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9789 | 0.180 |
Why?
|
Genetic Engineering | 2 | 2017 | 946 | 0.180 |
Why?
|
Sulfatases | 2 | 2010 | 43 | 0.170 |
Why?
|
Neonatal Screening | 2 | 2020 | 596 | 0.170 |
Why?
|
Mucormycosis | 1 | 2019 | 97 | 0.170 |
Why?
|
Busulfan | 2 | 2009 | 263 | 0.170 |
Why?
|
Quality of Life | 1 | 2020 | 12111 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2021 | 360 | 0.170 |
Why?
|
Hypercalcemia | 1 | 2020 | 405 | 0.160 |
Why?
|
Hydrazones | 1 | 2018 | 102 | 0.160 |
Why?
|
Benzylamines | 1 | 2018 | 221 | 0.160 |
Why?
|
Glycosaminoglycans | 1 | 2020 | 615 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 439 | 0.150 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 267 | 0.150 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 559 | 0.150 |
Why?
|
Cell Separation | 3 | 2019 | 1733 | 0.150 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 657 | 0.150 |
Why?
|
Gene Expression | 4 | 2017 | 7819 | 0.150 |
Why?
|
Child, Preschool | 13 | 2023 | 40440 | 0.140 |
Why?
|
Polyesters | 1 | 2018 | 362 | 0.140 |
Why?
|
Exosomes | 1 | 2021 | 395 | 0.140 |
Why?
|
Prodrugs | 1 | 2018 | 266 | 0.140 |
Why?
|
Laser Therapy | 1 | 2023 | 1047 | 0.140 |
Why?
|
Cerebrospinal Fluid | 1 | 2019 | 535 | 0.140 |
Why?
|
Hematopoiesis | 2 | 2019 | 2056 | 0.140 |
Why?
|
Coculture Techniques | 3 | 2017 | 1344 | 0.140 |
Why?
|
Growth Disorders | 1 | 2020 | 637 | 0.130 |
Why?
|
Vitamin B 12 | 1 | 2018 | 521 | 0.130 |
Why?
|
Adolescent | 14 | 2021 | 84401 | 0.130 |
Why?
|
Neoplasms | 2 | 2021 | 20941 | 0.130 |
Why?
|
Rare Diseases | 1 | 2019 | 546 | 0.130 |
Why?
|
Alleles | 3 | 2015 | 6952 | 0.120 |
Why?
|
Dependovirus | 1 | 2019 | 719 | 0.120 |
Why?
|
China | 1 | 2020 | 2199 | 0.120 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4497 | 0.120 |
Why?
|
Biotechnology | 1 | 2016 | 267 | 0.120 |
Why?
|
Spinal Cord | 2 | 2019 | 1812 | 0.120 |
Why?
|
Thrombocytopenia | 1 | 2022 | 1160 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1011 | 0.120 |
Why?
|
Age of Onset | 2 | 2022 | 3263 | 0.120 |
Why?
|
Infant | 8 | 2021 | 34337 | 0.120 |
Why?
|
Lymphoma, B-Cell | 1 | 2020 | 929 | 0.110 |
Why?
|
Genotype | 3 | 2015 | 12902 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2017 | 795 | 0.110 |
Why?
|
Cell Tracking | 1 | 2014 | 144 | 0.110 |
Why?
|
Gliosis | 2 | 2015 | 236 | 0.110 |
Why?
|
Databases, Genetic | 2 | 2021 | 1784 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2016 | 474 | 0.110 |
Why?
|
Neoplasm Metastasis | 1 | 2023 | 4896 | 0.110 |
Why?
|
Phenotype | 4 | 2021 | 16272 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1802 | 0.110 |
Why?
|
Fluorescent Dyes | 1 | 2020 | 1951 | 0.110 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 317 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 34776 | 0.110 |
Why?
|
Dextrans | 1 | 2014 | 590 | 0.110 |
Why?
|
Repressor Proteins | 2 | 2020 | 3042 | 0.110 |
Why?
|
Visual Cortex | 1 | 2020 | 1156 | 0.110 |
Why?
|
Hodgkin Disease | 1 | 2020 | 1410 | 0.110 |
Why?
|
Lysosomes | 1 | 2017 | 906 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2058 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2010 | 255 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2956 | 0.100 |
Why?
|
Doxorubicin | 1 | 2018 | 2226 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1230 | 0.100 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2011 | 87 | 0.100 |
Why?
|
Male | 25 | 2022 | 347096 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 2542 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1241 | 0.100 |
Why?
|
Enzymes | 1 | 2012 | 265 | 0.100 |
Why?
|
Bone Marrow Cells | 3 | 2019 | 2530 | 0.100 |
Why?
|
Macrophages | 3 | 2023 | 5689 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1486 | 0.100 |
Why?
|
Cells, Cultured | 8 | 2019 | 19485 | 0.100 |
Why?
|
Female | 24 | 2022 | 375449 | 0.090 |
Why?
|
Cell Line | 4 | 2019 | 16263 | 0.090 |
Why?
|
Multiple Sulfatase Deficiency Disease | 1 | 2009 | 2 | 0.090 |
Why?
|
Sandhoff Disease | 1 | 2009 | 13 | 0.090 |
Why?
|
U937 Cells | 1 | 2010 | 268 | 0.090 |
Why?
|
Myelin Sheath | 2 | 2015 | 652 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 7840 | 0.090 |
Why?
|
Image Enhancement | 1 | 2020 | 2924 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10971 | 0.090 |
Why?
|
Hemoglobinopathies | 1 | 2010 | 97 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1725 | 0.090 |
Why?
|
Enterococcus faecium | 1 | 2010 | 102 | 0.090 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2009 | 71 | 0.090 |
Why?
|
Pilot Projects | 2 | 2020 | 8104 | 0.090 |
Why?
|
Spleen | 2 | 2019 | 2375 | 0.090 |
Why?
|
Sphingolipids | 1 | 2010 | 165 | 0.090 |
Why?
|
Polydeoxyribonucleotides | 1 | 2009 | 120 | 0.080 |
Why?
|
Infant, Newborn | 7 | 2021 | 24985 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4744 | 0.080 |
Why?
|
Schwann Cells | 1 | 2009 | 201 | 0.080 |
Why?
|
Transplantation Chimera | 1 | 2011 | 610 | 0.080 |
Why?
|
HeLa Cells | 3 | 2009 | 3165 | 0.080 |
Why?
|
beta-Galactosidase | 1 | 2009 | 583 | 0.080 |
Why?
|
Carbon Radioisotopes | 1 | 2009 | 593 | 0.080 |
Why?
|
Bone Marrow Transplantation | 2 | 2015 | 2768 | 0.080 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2009 | 215 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2230 | 0.080 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2010 | 338 | 0.080 |
Why?
|
Genetic Testing | 1 | 2020 | 3422 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3711 | 0.080 |
Why?
|
Contrast Media | 1 | 2020 | 5237 | 0.080 |
Why?
|
Heterozygote | 1 | 2013 | 2825 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2331 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2938 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 1905 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2009 | 1872 | 0.070 |
Why?
|
Demyelinating Diseases | 1 | 2009 | 364 | 0.070 |
Why?
|
Cell Movement | 2 | 2012 | 5287 | 0.070 |
Why?
|
Blood-Brain Barrier | 1 | 2012 | 986 | 0.070 |
Why?
|
Pyrroles | 2 | 2010 | 1142 | 0.070 |
Why?
|
Neurophysiology | 1 | 2006 | 135 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10382 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2022 | 61761 | 0.070 |
Why?
|
Glioblastoma | 1 | 2020 | 3346 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4308 | 0.070 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2010 | 565 | 0.070 |
Why?
|
Microscopy, Confocal | 2 | 2009 | 1988 | 0.070 |
Why?
|
Cell Count | 1 | 2009 | 1871 | 0.070 |
Why?
|
Colony-Forming Units Assay | 2 | 2019 | 356 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11484 | 0.070 |
Why?
|
Cell Survival | 2 | 2018 | 5914 | 0.070 |
Why?
|
Fatal Outcome | 3 | 2021 | 1855 | 0.070 |
Why?
|
Remission Induction | 1 | 2010 | 2368 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2010 | 1173 | 0.060 |
Why?
|
Thymus Gland | 1 | 2009 | 1262 | 0.060 |
Why?
|
Viruses | 1 | 2008 | 358 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2569 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1646 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2016 | 38748 | 0.060 |
Why?
|
Fibroblast Growth Factors | 1 | 2010 | 885 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6398 | 0.060 |
Why?
|
DNA Damage | 1 | 2013 | 2466 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18339 | 0.060 |
Why?
|
Immunosuppressive Agents | 3 | 2010 | 4105 | 0.050 |
Why?
|
Neurodegenerative Diseases | 1 | 2011 | 1013 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2015 | 3739 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 2021 | 0.050 |
Why?
|
Transfection | 1 | 2010 | 5965 | 0.050 |
Why?
|
Ligands | 1 | 2009 | 3282 | 0.050 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2023 | 290 | 0.050 |
Why?
|
Lymphocytes | 1 | 2009 | 2642 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2019 | 5041 | 0.050 |
Why?
|
Granulocytes | 1 | 2023 | 550 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 417 | 0.050 |
Why?
|
Apoptosis | 3 | 2015 | 9756 | 0.050 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1646 | 0.050 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 170 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 432 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9579 | 0.050 |
Why?
|
Nervous System | 1 | 2004 | 560 | 0.050 |
Why?
|
Cytosine | 1 | 2021 | 223 | 0.050 |
Why?
|
Biomedical Research | 1 | 2016 | 3277 | 0.050 |
Why?
|
Stem Cell Transplantation | 2 | 2022 | 1630 | 0.050 |
Why?
|
Daunorubicin | 1 | 2020 | 150 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6227 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13576 | 0.050 |
Why?
|
Bone and Bones | 1 | 2010 | 2565 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8657 | 0.040 |
Why?
|
Acetates | 1 | 2020 | 308 | 0.040 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2022 | 698 | 0.040 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 2 | 2010 | 30 | 0.040 |
Why?
|
Cell Membrane | 1 | 2009 | 3813 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 420 | 0.040 |
Why?
|
Off-Label Use | 1 | 2020 | 166 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11324 | 0.040 |
Why?
|
Adrenal Insufficiency | 1 | 2020 | 169 | 0.040 |
Why?
|
Asparaginase | 1 | 2020 | 226 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2021 | 2895 | 0.040 |
Why?
|
Down-Regulation | 2 | 2020 | 3024 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3822 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2006 | 1888 | 0.040 |
Why?
|
Erythroid Precursor Cells | 1 | 2019 | 215 | 0.040 |
Why?
|
Homeostasis | 1 | 2009 | 3330 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 683 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2019 | 271 | 0.040 |
Why?
|
Vincristine | 1 | 2020 | 1050 | 0.040 |
Why?
|
Lysophosphatidylcholines | 1 | 2017 | 81 | 0.040 |
Why?
|
Neurons | 3 | 2019 | 9344 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 216 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2022 | 609 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 990 | 0.040 |
Why?
|
Pain | 2 | 2023 | 4830 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1518 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2022 | 74206 | 0.040 |
Why?
|
Milk Proteins | 1 | 2017 | 165 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 975 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1244 | 0.040 |
Why?
|
Graft Survival | 2 | 2019 | 3722 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2009 | 3012 | 0.040 |
Why?
|
Graft Rejection | 1 | 2010 | 4372 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2020 | 718 | 0.040 |
Why?
|
Benzamides | 1 | 2022 | 1372 | 0.040 |
Why?
|
Lymphoproliferative Disorders | 1 | 2019 | 528 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4501 | 0.040 |
Why?
|
Oligodendroglia | 1 | 2019 | 516 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 801 | 0.030 |
Why?
|
Goals | 1 | 2021 | 679 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1666 | 0.030 |
Why?
|
Visual Pathways | 1 | 2020 | 572 | 0.030 |
Why?
|
Young Adult | 2 | 2020 | 55781 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2071 | 0.030 |
Why?
|
Recurrence | 2 | 2022 | 8212 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2023 | 10477 | 0.030 |
Why?
|
Prednisone | 1 | 2020 | 1549 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 967 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13157 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8452 | 0.030 |
Why?
|
Immunization | 1 | 2019 | 1258 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1144 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2020 | 2205 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16630 | 0.030 |
Why?
|
Quinazolines | 1 | 2020 | 1365 | 0.030 |
Why?
|
Peripheral Nervous System | 1 | 2015 | 140 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1588 | 0.030 |
Why?
|
Liver | 1 | 2009 | 7494 | 0.030 |
Why?
|
Motor Activity | 1 | 2004 | 2712 | 0.030 |
Why?
|
Spectrophotometry | 1 | 2013 | 318 | 0.030 |
Why?
|
Endocytosis | 1 | 2018 | 992 | 0.030 |
Why?
|
Colorimetry | 1 | 2013 | 140 | 0.030 |
Why?
|
Adult | 4 | 2021 | 211615 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9716 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2513 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4999 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2018 | 2574 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1711 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1684 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5934 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6180 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1610 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2111 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1705 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2912 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1359 | 0.030 |
Why?
|
Astrocytes | 1 | 2019 | 1243 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13698 | 0.030 |
Why?
|
Phagocytosis | 1 | 2017 | 1570 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 6994 | 0.030 |
Why?
|
Autoimmunity | 1 | 2019 | 1320 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2019 | 13932 | 0.030 |
Why?
|
Drug Discovery | 1 | 2019 | 1028 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 1417 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3529 | 0.020 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2010 | 29 | 0.020 |
Why?
|
Animal Structures | 1 | 2010 | 23 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2001 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2980 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 113 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4758 | 0.020 |
Why?
|
Cytoprotection | 1 | 2010 | 201 | 0.020 |
Why?
|
Cell Lineage | 1 | 2019 | 2519 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2650 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 131 | 0.020 |
Why?
|
Sulfotransferases | 1 | 2010 | 148 | 0.020 |
Why?
|
Myelopoiesis | 1 | 2010 | 129 | 0.020 |
Why?
|
Lymphopoiesis | 1 | 2010 | 132 | 0.020 |
Why?
|
Silver Nitrate | 1 | 2009 | 12 | 0.020 |
Why?
|
Rats | 2 | 2020 | 24414 | 0.020 |
Why?
|
Antibodies | 1 | 2017 | 2417 | 0.020 |
Why?
|
Middle East | 1 | 2009 | 206 | 0.020 |
Why?
|
Medical Oncology | 1 | 2021 | 2162 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2010 | 292 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6893 | 0.020 |
Why?
|
Health Status | 1 | 2022 | 3983 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2150 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2019 | 13044 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3270 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 432 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2009 | 692 | 0.020 |
Why?
|
Nerve Net | 1 | 2020 | 2164 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2009 | 652 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2181 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2015 | 851 | 0.020 |
Why?
|
Cattle | 1 | 2013 | 3953 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2009 | 289 | 0.020 |
Why?
|
Exocytosis | 1 | 2009 | 353 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 631 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6728 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3713 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12991 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2010 | 513 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1187 | 0.020 |
Why?
|
Signal Transduction | 1 | 2010 | 23448 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 2745 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3389 | 0.020 |
Why?
|
Axons | 1 | 2015 | 1688 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 6878 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5171 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3785 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2010 | 691 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 723 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4313 | 0.020 |
Why?
|
Pediatrics | 1 | 2021 | 3441 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 2022 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12817 | 0.020 |
Why?
|
Nitriles | 1 | 2010 | 940 | 0.020 |
Why?
|
Registries | 1 | 2021 | 7898 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 2724 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 8918 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1057 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10007 | 0.020 |
Why?
|
Electroencephalography | 1 | 2019 | 6010 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2004 | 812 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5913 | 0.010 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 964 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9379 | 0.010 |
Why?
|
Adenoviridae | 1 | 2007 | 1102 | 0.010 |
Why?
|
Luciferases | 1 | 2004 | 734 | 0.010 |
Why?
|
Cysteine | 1 | 2007 | 863 | 0.010 |
Why?
|
Muscles | 1 | 2007 | 1602 | 0.010 |
Why?
|
Isoenzymes | 1 | 2007 | 1748 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7254 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 15420 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 24031 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9245 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 2015 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12080 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21591 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4052 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2408 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8487 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 51869 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4257 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2009 | 2860 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2785 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4799 | 0.010 |
Why?
|
Stem Cells | 1 | 2010 | 3576 | 0.010 |
Why?
|
Blotting, Western | 1 | 2004 | 5236 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10251 | 0.010 |
Why?
|
Sepsis | 1 | 2010 | 2504 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5457 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18301 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 7921 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12180 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20750 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7814 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40186 | 0.000 |
Why?
|